The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Avetisov S.E.
Krasnov Research Institute of Eye Disease;
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Fisenko V.P.
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Zhuravlev A.S.
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Agaeva L.M.
Research Institute of Eye Diseases
Pharmaceutical aspects of medicated myopia control
Journal: Russian Annals of Ophthalmology. 2020;136(4): 310‑316
Views: 2716
Downloaded: 135
To cite this article:
Avetisov SE, Fisenko VP, Zhuravlev AS, Agaeva LM. Pharmaceutical aspects of medicated myopia control. Russian Annals of Ophthalmology.
2020;136(4):310‑316. (In Russ.)
https://doi.org/10.17116/oftalma2020136042310
The article presents data on the mechanism of various approaches of drug-induced myopia control and their potential effectiveness, and analyses promising options for medicated correction of myopia.
Keywords:
Authors:
Avetisov S.E.
Krasnov Research Institute of Eye Disease;
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Fisenko V.P.
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Zhuravlev A.S.
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Agaeva L.M.
Research Institute of Eye Diseases
Received:
13.01.2020
Accepted:
12.02.2020
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.